Best Stock Trading Journal in 2026: What Equity Traders Need

Most trading journal comparisons treat every asset class the same. Stocks have mechanics that forex and futures do not, and a journal that handles them badly will quietly corrupt the numbers you rely on.

This guide covers what is specific to equities. For full pricing and side-by-side comparisons of the tools themselves, see our main trading journal comparison.

Partial fills are the real stock-specific problem

Enter 1,000 shares and you may get twelve executions at eleven prices. Those twelve fills are one trade, one decision and one thesis — but many journals, and most spreadsheet setups, record them as twelve.

The damage is not cosmetic. It inflates your trade count, which makes your sample look larger and more significant than it is. It destroys your average entry, which is the number your stop distance is measured from. And since R-multiple is calculated from entry and stop, every downstream metric — expectancy, average win in R, profit factor — inherits the error.

What you need is grouping: all executions belonging to one position collapsed into a single trade with a size-weighted average entry and exit. Check this explicitly before committing to a tool. It is easy to verify — import a day with scaled entries and see whether the result reads as one trade or several.

Commissions and fees change the answer

In equities, costs are more variable than traders model. Per-share pricing, per-trade pricing, ECN routing fees, regulatory fees on sells — none of it is large individually, and together it can consume a meaningful share of edge on strategies with small average R.

The practical test: if your average win is 0.4R and your costs amount to 0.05R per trade, you have just lost an eighth of your edge to something your gross P&L never showed you. A journal reporting gross-only results will show positive expectancy on a strategy that loses money net of costs.

Make sure whatever you use either imports fees from your broker or lets you enter them. Then read your expectancy net, not gross.

Share counts are not comparable — R-multiples are

"I bought 500 shares" says nothing about risk. Five hundred shares of a $20 stock with a $0.50 stop risks $250. Five hundred shares of a $400 stock with an $8 stop risks $4,000. Same share count, sixteen times the risk.

This is why equity traders in particular need results expressed in R-multiples rather than share counts or raw dollars. R normalises for both price and size, so a trade on a low-priced stock and a trade on a high-priced one become directly comparable — which is the entire point of keeping records.

Size the position from your stop distance, using the standard formula, and let the share count be an output:

Position size = (Account equity × Risk %) ÷ |Entry − Stop|

Our position size calculator does this, and the R-multiple calculator converts results once the trade is closed.

If you are under the PDT threshold

US traders with under $25,000 in a margin account are limited to three day trades in a rolling five-day window. That constraint belongs in your journal, because it changes the meaning of your data.

When the rule forces you to hold overnight or skip a setup entirely, that is not a discretionary decision — but without a note it looks identical to one when you review three weeks later. Tag those trades. Otherwise you will diagnose a discipline problem that is actually a regulatory one, or miss a real discipline problem hiding behind the excuse.

What to check before choosing

1. Your broker's CSV export. This causes more migration pain than any feature gap. Export a sample and confirm the tool accepts it before you commit.
2. Fill grouping, as above.
3. Commission and fee handling.
4. Per-setup analytics — expectancy and R by strategy tag, not one blended number.
5. Screenshot storage. Chart context ages fast; a screenshot attached to the trade is worth more than the note you will write from memory.
6. Options handling, if you trade them alongside equities — specifically whether multi-leg positions stay together.

Options in 2026

All of the tools in our main comparison handle equities competently — this is the asset class the category was built around, so the differences are less about whether stocks are supported and more about price, interface, and how much tooling you want alongside the journal.

Briefly, and with pricing verified in September 2026:

• TradeZella — $35-$99/mo. The most feature-complete, including backtesting and replay. See TradeLens vs TradeZella.
• Tradervue — $29.95-$49.95/mo. The strongest choice if you trade in a room or work with a coach. See TradeLens vs Tradervue.
• Edgewonk — price not published on their site. Built around psychology tracking. See TradeLens vs Edgewonk.
• TradeLens — our own: $9/mo Starter, $19/mo Pro, unlimited trades on both, CSV import on every plan, per-setup analytics, 7-day trial with no card. No backtesting or trade replay.
• A spreadsheet — free, and genuinely fine at low volume, though fill grouping is exactly the manual work that gets skipped. See the spreadsheet comparison.

The metric that matters for equity traders

Once your fills are grouped and your costs are accounted for, the number to watch is expectancy per setup tag — not your account balance, and not your win rate.

A blended figure routinely hides the fact that one setup carries your entire edge while another quietly loses money. That pattern is invisible in a total P&L and obvious the moment you group by setup, which is the single highest-value thing a stock trading journal does for you. Our guide to the metrics that matter covers how they fit together.